271980.KS KSC
Jeil Pharmaceutical Co.,Ltd
1W: +0.3%
1M: -12.4%
3M: -1.3%
YTD: -32.1%
1Y: -28.1%
3Y: -46.1%
5Y: -76.9%
₩10,000.00 ($7.44)
-30.00 (-0.30%)
Weekly Expected Move ±1.7%
₩9666
₩9833
₩10000
₩10167
₩10334
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$5.7B
-277.1% ▼
Capital Expenditures
$8.0B
-21.5% ▼
5Y CAGR: +22.9%
Free Cash Flow
-$13.7B
-303.6% ▼
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$4.6B
-122.5% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$15.0B | -$15.0B | $5.2B | -$30.1B | $23.4B |
| Depreciation & Amort. | $9.1B | $8.9B | $9.8B | $11.3B | $12.3B |
| Stock-Based Comp. | $163M | $472M | $578M | $1.0B | $0 |
| Change in Working Capital | $14.6B | -$15.2B | -$20.7B | -$13.8B | -$36.5B |
| Other Non-Cash Items | $1.7B | $5.7B | $162M | $34.8B | -$4.9B |
| Operating Cash Flow | $19.1B | -$15.1B | -$5.0B | $3.2B | -$5.7B |
| — Investing Activities — | |||||
| Capital Expenditures | -$5.4B | -$17.0B | -$6.1B | -$4.3B | -$9.1B |
| Acquisitions (Net) | -$1.5B | $26.0B | $88M | $0 | $12M |
| Investment Purchases | -$1.9B | -$26.0B | -$5.6B | -$7.4B | -$18.3B |
| Investment Sales | $655M | $1.9B | $3.0B | $6.1B | $12.0B |
| Other Investing | $110M | $2.1B | -$3.4B | -$1.7B | $0 |
| Investing Cash Flow | -$8.0B | -$12.9B | -$11.9B | -$7.3B | -$15.3B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$12.4B | $11.3B | $21.7B | $6.2B | $19.5B |
| Stock Repurchased | -$810M | -$397M | $0 | $0 | $0 |
| Dividends Paid | -$1.0B | -$948M | -$728M | -$728M | $0 |
| Other Financing | $25.3B | $23.7B | -$2.2B | -$2.2B | -$2.2B |
| Financing Cash Flow | $11.1B | $33.6B | $18.8B | $23.1B | $17.0B |
| Net Change in Cash | $22.1B | $5.5B | $1.5B | $20.5B | -$4.6B |
| Cash End of Period | $26.0B | $31.4B | $33.0B | $53.5B | $48.9B |
| Free Cash Flow | $13.7B | -$32.1B | -$14.6B | -$3.4B | -$13.7B |